Skip to main content
Top
Published in: Abdominal Radiology 7/2016

01-07-2016 | Classics in Abdominal Imaging

The hyperattenuating ring sign of acute epiploic appendagitis

Authors: Qiong Han, Rashmi T. Nair, David J. DiSantis

Published in: Abdominal Radiology | Issue 7/2016

Login to get access

Excerpt

Epiploic appendages are small fat-containing pouches that protrude from the serosal surface of most of the colon. Usually, the normal epiploic appendages are not visible on CT, though adjacent ascites can reveal them (Fig 1).
Literature
1.
go back to reference Danielson K, et al. (1986) Epiploic appendagitis: CT characteristics. J Comput Assist Tomogr. 10:142–143CrossRefPubMed Danielson K, et al. (1986) Epiploic appendagitis: CT characteristics. J Comput Assist Tomogr. 10:142–143CrossRefPubMed
2.
go back to reference Rioux M, et al. (1994) Primary epiploic appendagitis: clinical, US, and CT findings in 14 cases. Radiology. 191(2):523–526CrossRefPubMed Rioux M, et al. (1994) Primary epiploic appendagitis: clinical, US, and CT findings in 14 cases. Radiology. 191(2):523–526CrossRefPubMed
3.
Metadata
Title
The hyperattenuating ring sign of acute epiploic appendagitis
Authors
Qiong Han
Rashmi T. Nair
David J. DiSantis
Publication date
01-07-2016
Publisher
Springer US
Published in
Abdominal Radiology / Issue 7/2016
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0641-y

Other articles of this Issue 7/2016

Abdominal Radiology 7/2016 Go to the issue

Commentary

Book Review

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.